Cart
sales@molnova.com
Conduritol B epoxide
CAS No. 6090-95-5
Conduritol B epoxide( —— )
Catalog No. M24607 CAS No. 6090-95-5
Conduritol B epoxide is an irreversible inhibitor of β-glucosidase (GCase).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 39 | In Stock |
|
| 10MG | 76 | In Stock |
|
| 25MG | 100 | In Stock |
|
| 50MG | 162 | In Stock |
|
| 100MG | 241 | In Stock |
|
| 200MG | 361 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameConduritol B epoxide
-
NoteResearch use only, not for human use.
-
Brief DescriptionConduritol B epoxide is an irreversible inhibitor of β-glucosidase (GCase).
-
DescriptionConduritol B epoxide is an irreversible inhibitor of β-glucosidase (GCase).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCytoskeleton/Cell Adhesion Molecules
-
TargetGlucokinase
-
Recptorα-glucosidase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number6090-95-5
-
Formula Weight162.1
-
Molecular FormulaC6H8O5
-
Purity>98% (HPLC)
-
SolubilityDMSO:50 mg/mL (308.38 mM; Need ultrasonic);Water:20 mg/mL (123.35 mM)
-
SMILESOC(C1OC1C(C1O)O)C1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Liou B, et al. Modulating ryanodine receptors with dantrolene attenuates neuronopathic phenotype in Gaucher disease mice. Hum Mol Genet. 2016 Sep 20. pii: ddw322. [Epub ahead of print]
molnova catalog
related products
-
Naringinase
Naringinase, a hydrolytic enzymatic complex, possesses the activity of both α-L-rhamnosidase and β-D-glucosidase. Naringinase has wide occurrence in nature. Naringinase can be used in the biotransformation of steroids, antibiotics, and mainly on glycoside
-
XL388
XL388 is a highly effective, specifc, ATP-competitive inhibitor of mTOR ( IC50: 9.9 nM), 1000-fold selectivity than the closely related PI3K kinases.
-
AZD-1656
AZD-1656 is a glucokinase activator (GKA) that can cause dose-limiting hypoglycemia in normal animals used in embryofetal development studies and type 2 diabetes.
